A novel role of complement in mobilization: Immunodeficient mice are poor granulocyte-colony stimulating factor mobilizers because they lack complement-activating immunoglobulins

Stem Cells

Volumn 25, Issue 12, 2007, Pages 3093-3100

  Reca, Ryan ^a   Cramer, Daniel ^a   Yan, Jun ^a   Laughlin, Mary J ^b   Janowska Wieczorek, Anna ^c   Ratajczak, Janina ^a   Ratajczak, Mariusz Z ^a,d  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

C3; C5; Complement; CXCR4; Granulocyte colony stimulating factor; Mobilization; Zymosan

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; STROMAL CELL DERIVED FACTOR 1; ZYMOSAN;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; COLONY FORMING UNIT; COMBINED IMMUNODEFICIENCY; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INNATE IMMUNITY; LEUKOCYTE COUNT; MACROPHAGE; MOUSE; NONHUMAN; SCID MOUSE;

ANIMALS; CELL MOVEMENT; COMPLEMENT ACTIVATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; IMMUNOGLOBULINS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID;

ANIMALIA; MUS;

EID: 37349076287     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0525     Document Type: Article

References (44)

1. To LB, Haylock DN, Simmons PJ et al. The biology and clinical uses of blood stem cells. Blood 1997;89:2233-2258.
2. Ratajczak MZ, Reca R, Wysoczynski M et al. Modulation of the SDF-1-CXCR4 axis by the third complement component (C3) - implications for trafficking of CXCR4+ stem cells. Exp Hematol 2006;34:986-995.
3. Kucia M, Reca R, Miekus K et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: Pivotal role of the SDF-1-CXCR4 axis. STEM CELLS 2005;23:879-894.
4. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005;106:1901-1910.
5. Lapidot T, Petit I. Current understanding of stem cell mobilization: The roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002;30:973-981.
6. Winkler IG, Levesque JP. Mechanisms of hematopoietic stem cell mobilization: When innate immunity assails the cells that make blood and bone. Exp Hematol 2006;34:996-1009.
7. Fruehauf S, Seeger T, Topaly J. Innovative strategies for PBPC mobilization. Cytotherapy 2005;7:438-446.
8. Papayannopoulou T. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood 2004;103:1580-1585.
9. Matsunaga T, Sakamaki S, Kohgo Y et al. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 1993;11:103-108.
10. Link DC. Mechanisms of granulocyte colony-stimulating factor-induced hematopoietic progenitor-cell mobilization. Semin Hematol 2000;37:25-32.
11. Vos O, Wilschut IJ. Further studies on mobilization of CFUs. Cell Tissue Kinet 1979;12:257-267.
12. Sweeney EA, Priestley GV, Nakamoto B et al. Mobilization of stem/progenitor cells by sulfated polysaccharides does not require selectin presence. Proc Natl Acad Sci U S A 2000;97:6544-6549.
13. Laterveer L, Lindley IJ, Hamilton MS et al. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 1995;85:2269-2275.
14. King AG, Horowitz D, Dillon SB et al. Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRObeta. Blood 2001;97:1534-1542.
15. Mohle R, Rafii S, Moore MA. The role of endothelium in the regulation of hematopoietic stem cell migration. STEM CELLS 1998;16(suppl 1):159-165.
16. Liles WC, Broxmeyer HE, Rodger E et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003;102:2728-2730.
17. Ratajczak J, Reca R, Kucia M et al. Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow. Blood 2004;103:2071-2078.
18. Molendijk WJ, van Oudenaren A, van Dijk H et al. Complement split product C5a mediates the lipopolysaccharide-induced mobilization of CFU-s and haemopoietic progenitor cells, but not the mobilization induced by proteolytic enzymes. Cell Tissue Kinet 1986;19:407-417.
19. Sekhsaria S, Fleisher TA, Vowells S et al. Granulocyte colony-stimulating factor recruitment of CD34+ progenitors to peripheral blood: Impaired mobilization in chronic granulomatous disease and adenosine deaminase-deficient severe combined immunodeficiency disease patients. Blood 1996;88:1104-1112.
20. Ratajczak MZ, Reca R, Wysoczynski M et al. Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells. Leukemia 2004;18:1482-1490.
21. Reca R, Mastellos D, Majka M et al. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood 2003;101:3784-3793.
22. Reca R, Wysoczynski M, Yan J et al. The role of third complement component (C3) in homing of hematopoietic stem/progenitor cells into bone marrow. Adv Exp Med Biol 2006;586:35-51.
23. Levesque JP, Hendy J, Takamatsu Y et al. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp Hematol 2002;30:440-449.
24. Cramer DE, Allendorf DJ, Baran JT et al. Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow injury. Blood 2006;107:835-840.
25. Zhang M, Austen WG, Jr., Chiu I et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A 2004;101:3886-3891.
26. Vogel CW, Muller-Eberhard HJ. The cobra complement system: I. The alternative pathway of activation. Dev Comp Immunol 1985;9:311-325.
27. Roberts AW, Foote S, Alexander WS et al. Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor. Blood 1997;89:2736-2744.
28. Fleming SD. Natural antibodies, autoantibodies and complement activation in tissue injury. Autoimmunity 2006;39:379-386.
29. Vos O, Buurman WA, Ploemacher RE. Mobilization of haemopoietic stem cells (CFU) into the peripheral blood of the mouse; effects of endotoxin and other compounds. Cell Tissue Kinet 1972;5:467-479.
30. Reca R, Egilmetz N, Hansen R et al. Immunodeficient mice are poor mobilizers - novel evidence that demonstrates a pivotal role of complement in triggering the mobilization of HSPC. Paper presented at: American Society of Hematology; 2005; Atlanta, Georgia.
31. Yan J, Vetvicka V, Xia Y et al. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). J Immunol 1999;163:3045-3052.
32. Walport MJ. Complement. First of two parts. N Engl J Med 2001;344:1058-1066.
33. Walport MJ. Complement. Second of two parts. N Engl J Med 2001;344:1140-1144.
34. Levesque JP, Takamatsu Y, Nilsson SK et al. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 2001;98:1289-1297.
35. Pruijt JF, Fibbe WE, Laterveer L et al. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc Natl Acad Sci U S A 1999;96:10863-10868.
36. Semerad CL, Christopher MJ, Liu F et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 2005;106:3020-3027.
37. Huber-Lang M, Sarma JV, Zetoune FS et al. Generation of C5a in the absence of C3: A new complement activation pathway. Nat Med 2006;12:682-687.
38. Levesque JP, Hendy J, Winkler IG et al. Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp Hematol 2003;31:109-117.
39. Canales MA, Arrieta R, Gomez-Rioja R et al. Induction of a hypercoagulability state and endothelial cell activation by granulocyte colony-stimulating factor in peripheral blood stem cell donors. J Hematother Stem Cell Res 2002;11:675-681.
40. Stief T. G-CSF enhances cellular fibrinolysis. Clin Appl Thromb Hemost 2006;12:122.
41. Topcuoglu P, Arat M, Dalva K et al. Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors. Bone Marrow Transplant 2004;33:171-176.
42. Kessinger A, Mann S, Murphy BO et al. Circulating factors may be responsible for murine strain-specific responses to mobilizing cytokines. Exp Hematol 2001;29:775-778.
43. Chen NJ, Mirtsos C, Suh D et al. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 2007;446:203-207.
44. Fukuda S, Bian H, King AG et al. The chemokine Gro-β mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. Blood 2007;110:860-869.